Randomised clinical trials have been the mainstay of pharmaceutical product development for decades, but will they be designed and carried out the same way in future? With trials tipped to get smaller and patient selection more complex as pharma’s blockbuster model is dismantled, interactive technologies, adaptive designs and new ways to recruit and monitor patients will come to the fore.
21-Aug-2012 - The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer....
20-Aug-2012 - DaVita Clinical Research has opened a Phase I facility focussed on kidney research in a bid to meet a “growing demand” for renal trials.
16-Aug-2012 - Theorem and Gallus say their new biologics manufacturing partnership is aimed at giving a “leg up” to drugsmakers in emerging markets looking to market products in the US.
14-Aug-2012 - Icon has boosted its Phase I translational medicine services in Manchester, UK, in preparation for what it believes will be a boom in the drug development area.
13-Aug-2012 - BioClinica says the next eClinical revolution will be in programmes combining functionalities tailored to a client's specific needs.
09-Aug-2012 - ResearchNurses.co will conduct home visits in clinical trials for three Big Pharma firms after forging an agreement with Nottingham University Hospitals Research and Innovation Department.
07-Aug-2012 - Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and...
01-Aug-2012 - Medidata beat analyst expectations in this year’s Q2 results after inking a five-year $100m clinical cloud deal – the largest in the firm’s history.
31-Jul-2012 - BioFocus and Activiomics have teamed up to offer a drug discovery and biomarker service which it says will improve the identification of novel targets.
30-Jul-2012 - Outcome-based payment for CRO services is the “wave of the future” for pharmaceutical outsourcing, according to iGate.
09-Jul-2012 - iGATE says its new information management platform will provide a 70 per cent decrease in content management costs for the drug development process.
05-Jul-2012 - ‘Merge CDMO and CRO activities to fix the holes in the early phase clinical research industry’, said Quotient Clinical’s CEO Mark Egerton.
04-Jul-2012 - Argentina’s clinical trial market will hit $76m (EUR60.4) by 2015 with growth driven by low costs, a good regulatory environment and large patient populations, according to a new study.
02-Jul-2012 - A quarter of procedures carried out during clinical trials may be pointless according to a new study, which suggests that this unnecessary work costs around $5bn (€3.96bn) a year. ...
28-Jun-2012 - It seems service quality really does mean bigger profits for CROs serving the pharma and biopharma industries, according to Industry Standard Research’s (ISR) new report.
28-Jun-2012 - eClinical integration was a hot topic at DIA this week with OmniComm, Datatrak and Merge Healthcare all showing updated systems.
27-Jun-2012 - “Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.
26-Jun-2012 - Quotient and Capsugel have teamed up to tackle drug delivery challenges in lipid-based formulations with new assessment and development services.
26-Jun-2012 - Roowin says it will be one of the first small batch GMP makers for Phase I & II clinical trials after moving into a new facility in Riom, France.
21-Jun-2012 - Quintiles has teamed up with the Shanghai Clinical Research Centre (SCRC) to ramp-up its biopharmaceutical lab testing services in China.
20-Jun-2012 - Outsourcing-Pharma.com presents a roundup of eClinical news, including developments at Parexel, Datatrak, and MedNet.
14-Jun-2012 - Regulation of clinical trials in emerging markets is now too strict and is prompting sponsors and CROs to adopt “one-size-fits-all” designs, according to a new study.
11-Jun-2012 - Outsourcing is no longer a need but a "must" to lift the flat biologics discovery industry, according to a new analysis.
06-Jun-2012 - Catalent has upgraded its North Carolina, US, sterile development and analytics plant to increase its aseptic fill-finish activities four-fold in a bid to boost its integrated biologics offering.
05-Jun-2012 - Creation of long-term biopharma relationships is hindered by continued pursuit of short-term gains, according to Quintiles’ New Health Report.